Glaukos Corp Receivables Turnover Ratio (GKOS), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Glaukos Corp  (NYSE: GKOS)
 

Glaukos Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Glaukos Corp's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 4.29, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the second quarter 2026. Average collection period, for Glaukos's accounts receivable remained unchanged at 85 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 265 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 1862 to 2086.

What is Receivable Turnover Ratio?
What is Glaukos Corp Selling?


What is Receivable Turnover Ratio?





GKOS Receivables Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Receivable Change 67.38 % 67.33 % 78.8 % 74.95 % 62.03 %
Y / Y Revenue Change 50.63 % 41.26 % -70.54 % 38.11 % 29.52 %
Receivable Turnover Ratio (TTM) 4.29 4.27 4.35 5.98 6.37
GKOS's Total Ranking # 2086 # 1862 # 2061 # 2116 # 1844
Accounts Receivable average collection period days 85 85 84 61 57
Seq. Receivable Change 16.05 % 10.2 % 10.06 % 18.92 % 16.01 %
Seq. Revenue Change 23.55 % 377.18 % -76.28 % 7.69 % 15.87 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 115
Healthcare Sector # 266
Overall Market # 2086

Receivable Turnover Ratio Statistics
High Average Low
1.06 0.54 0.23
(Dec 31 2017)   (Mar 31 2021)






Financial Statements
Glaukos's Accounts Receivable $ 139 Millions Visit GKOS's Balance sheet
Glaukos's Sales TTM $ 500 Millions Visit GKOS's Income Statement
Sources of GKOS's Revenues Visit GKOS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
GKOS's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
GKOS's Growth Rates GKOS's Roa GKOS's Inventory Turnover Ratio GKOS's Dividend Comparisons
GKOS's Profitability Ratios GKOS's Roi GKOS's Asset Turnover Ratio GKOS's Dividend Growth
GKOS's Valuation Ratios GKOS's Roe GKOS's Financial Strength Ratios GKOS's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026
Encompass Health Corporation  9.57 $ 6,206.100  Millions$ 648.325  Millions
Harmony Biosciences Holdings inc   9.22 $ 960.191  Millions$ 104.164  Millions
Ardent Health Inc   9.16 $ 6,405.940  Millions$ 699.363  Millions
Bioaffinity Technologies Inc   9.11 $ 5.901  Millions$ 0.648  Millions
Guardant Health Inc   8.84 $ 1,183.105  Millions$ 133.772  Millions
Scientific Industries Inc   8.83 $ 5.728  Millions$ 0.649  Millions
Cannapharmarx Inc   8.65 $ 1.699  Millions$ 0.196  Millions
Septerna Inc   8.64 $ 98.882  Millions$ 11.445  Millions
10x Genomics Inc   8.63 $ 616.566  Millions$ 71.463  Millions
Pediatrix Medical Group Inc   8.54 $ 1,950.625  Millions$ 228.297  Millions
Ensign Group Inc  8.50 $ 5,486.708  Millions$ 645.470  Millions
Inogen Inc   8.47 $ 354.304  Millions$ 41.817  Millions
Axogen inc   8.42 $ 251.174  Millions$ 29.846  Millions
Adapthealth Corp   8.14 $ 3,226.709  Millions$ 396.643  Millions
Atricure Inc   8.08 $ 567.747  Millions$ 70.232  Millions
Alphatec Holdings Inc   7.94 $ 814.780  Millions$ 102.662  Millions
Tenet Healthcare Corp  7.92 $ 21,812.000  Millions$ 2,752.500  Millions
Henry Schein Inc   7.91 $ 13,602.000  Millions$ 1,719.000  Millions
Pacs Group Inc   7.78 $ 5,551.038  Millions$ 713.483  Millions
Vycor Medical Inc   7.68 $ 1.807  Millions$ 0.235  Millions
Idexx Laboratories Inc  7.65 $ 4,553.792  Millions$ 595.549  Millions
Sharps Technology Inc   7.65 $ 2.468  Millions$ 0.323  Millions
Natera Inc   7.61 $ 2,707.077  Millions$ 355.618  Millions
Quest Diagnostics Inc  7.56 $ 11,560.000  Millions$ 1,529.250  Millions
Iridex Corp  7.49 $ 51.044  Millions$ 6.816  Millions
Novocure Limited  7.46 $ 699.193  Millions$ 93.686  Millions
Intuitive Surgical Inc   7.46 $ 11,296.300  Millions$ 1,513.950  Millions
Beta Bionics Inc   7.43 $ 119.513  Millions$ 16.092  Millions
Maravai Lifesciences Holdings Inc   7.39 $ 207.886  Millions$ 28.147  Millions
Foxo Technologies Inc   7.27 $ 24.846  Millions$ 3.420  Millions

Date modified: 2026-08-13T08:43:40+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.